These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 30611410)

  • 1. At last, an orally active gonadotropin-releasing hormone antagonist.
    Paulson RJ
    Fertil Steril; 2019 Jan; 111(1):30-31. PubMed ID: 30611410
    [No Abstract]   [Full Text] [Related]  

  • 2. Synthesis of orally active small-molecule gonadotropin-releasing hormone antagonists.
    Tucci FC; Chen C
    Curr Opin Drug Discov Devel; 2004 Nov; 7(6):832-47. PubMed ID: 15595444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Using of gonadotropin releasing hormone antagonist protocol: a committee opinion].
    Chinese Society of Reproductive Medicine, Chinese Medical Association
    Zhonghua Fu Chan Ke Za Zhi; 2015 Nov; 50(11):805-9. PubMed ID: 26887765
    [No Abstract]   [Full Text] [Related]  

  • 4. Oral delivery of oil-based formulation for a novel synthetic cationic peptide of GnRH (gonadotropin-releasing hormone) antagonist for prostate cancer treatment.
    Zhang G; Wang T; Gao L; Quan D
    Int J Pharm; 2013 Jun; 450(1-2):138-44. PubMed ID: 23623791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progesterone administration route in gonadotropin-releasing hormone antagonist cycles.
    Bahceci M; Ulug U
    Fertil Steril; 2010 Aug; 94(3):e47; author reply e48. PubMed ID: 20627239
    [No Abstract]   [Full Text] [Related]  

  • 6. Elagolix (Orilissa)--an oral GnRH antagonist for endometriosis pain.
    Med Lett Drugs Ther; 2018 Sep; 60(1556):158-160. PubMed ID: 30383729
    [No Abstract]   [Full Text] [Related]  

  • 7. The use of gonadotropin-releasing hormone antagonist in ovarian stimulation.
    Olivennes F
    Clin Obstet Gynecol; 2006 Mar; 49(1):12-22. PubMed ID: 16456339
    [No Abstract]   [Full Text] [Related]  

  • 8. Gonadotrophin-releasing hormone antagonists for assisted conception.
    Al-Inany H; Aboulghar M
    Cochrane Database Syst Rev; 2001; (4):CD001750. PubMed ID: 11687120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Administration of gonadotropin-releasing hormone antagonist from day 1 of stimulation in in vitro fertilization.
    Kolibianakis EM; Zikopoulos K; Smitz J; Camus M; Tournaye H; Van Steirteghem AC; Devroey P
    Fertil Steril; 2004 Jul; 82(1):223-6. PubMed ID: 15237018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulation of the young poor responder: comparison of the luteal estradiol/gonadotropin-releasing hormone antagonist priming protocol versus oral contraceptive microdose leuprolide.
    Shastri SM; Barbieri E; Kligman I; Schoyer KD; Davis OK; Rosenwaks Z
    Fertil Steril; 2011 Feb; 95(2):592-5. PubMed ID: 21074154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An overview of GnRH antagonists in infertility treatments. Introduction.
    Shapiro DB
    Fertil Steril; 2003 Jul; 80 Suppl 1():S1-7; discussion S32-4. PubMed ID: 12831912
    [No Abstract]   [Full Text] [Related]  

  • 12. Delivery of Peptidic Gonadotropin Releasing Hormone Antagonists.
    AlSheyyab RY; Al-Taani BM; Obeidat RM; Alsmadi MM; Masaedeh RK; Sabat RN
    Curr Drug Deliv; 2018; 15(5):602-609. PubMed ID: 29446744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrashort gonadotropin-releasing hormone agonist combined with flexible multidose gonadotropin-releasing hormone antagonist for poor responders in in vitro fertilization/embryo transfer programs.
    Orvieto R; Kruchkovich J; Rabinson J; Zohav E; Anteby EY; Meltcer S
    Fertil Steril; 2008 Jul; 90(1):228-30. PubMed ID: 17681292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discussion on letrozole-Gn-antagonist group needing an early start of antagonist.
    Chen X
    Fertil Steril; 2011 Jun; 95(8):e79; author reply e80. PubMed ID: 21605860
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical application of GnRH antagonist to uterine fibroid].
    Ayabe T
    Nihon Rinsho; 2006 Apr; 64 Suppl 4():116-21. PubMed ID: 16689295
    [No Abstract]   [Full Text] [Related]  

  • 16. Assessment of luteinizing hormone level in the gonadotropin-releasing hormone antagonist protocol.
    Griesinger G; Dawson A; Schultze-Mosgau A; Finas D; Diedrich K; Felberbaum R
    Fertil Steril; 2006 Mar; 85(3):791-3. PubMed ID: 16500366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of a single dose of gonadotropin-releasing hormone antagonist with nitric oxide and embryo quality in in vitro fertilization cycles.
    Lee TH; Wu MY; Chen HF; Chen SU; Ho HN; Yang YS
    Fertil Steril; 2006 Oct; 86(4):1020-2. PubMed ID: 16963037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Administration of a gonadotropin-releasing hormone antagonist during the 3 days before the initiation of the in vitro fertilization/intracytoplasmic sperm injection treatment cycle: impact on ovarian stimulation. A pilot study.
    Blockeel C; Riva A; De Vos M; Haentjens P; Devroey P
    Fertil Steril; 2011 Apr; 95(5):1714-9.e1-2. PubMed ID: 21300334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral contraceptive pretreatment significantly reduces ongoing pregnancy likelihood in gonadotropin-releasing hormone antagonist cycles: an updated meta-analysis.
    Griesinger G; Kolibianakis EM; Venetis C; Diedrich K; Tarlatzis B
    Fertil Steril; 2010 Nov; 94(6):2382-4. PubMed ID: 20537631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Letrozole and gonadotropins versus luteal estradiol and gonadotropin-releasing hormone antagonist protocol in women with a prior low response to ovarian stimulation.
    Elassar A; Engmann L; Nulsen J; Benadiva C
    Fertil Steril; 2011 Jun; 95(7):2330-4. PubMed ID: 21514582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.